Patents by Inventor Robert Kendall

Robert Kendall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957860
    Abstract: A medical device that may include an elongate member having a proximal end and a distal end, and a lumen disposed through the elongate member is disclosed. The medical device may also include an opening disposed at the distal end of the elongate member in communication with the lumen, and a pushing element disposed with the lumen. The medical device may also include at least one fiducial disposed within the lumen and distal to the pushing element, and a separating mechanism disposed at the distal end of the elongate member. The separating mechanism may be configured to apply a separating force to deploy the at least one fiducial.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: April 16, 2024
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Shawn Ryan, Joseph A. Levendusky, Robert B. DeVries, William Cole Lafferty, Andrew Kendall Hollett, Brian Intoccia
  • Publication number: 20240101274
    Abstract: An electric pushback vehicle includes a frame having a forward portion and a rear portion. The vehicle further includes front drive axle and a rear drive axle configured to communicate power to ground engaging members. A traction battery is housed within the electric pushback vehicle and provides electric power to an electric motor to drive an output shaft. A transmission is connected to receive mechanical power from the electric motor through a torque converter.
    Type: Application
    Filed: October 13, 2020
    Publication date: March 28, 2024
    Inventors: Trevor Douglas ROEBUCK, Brian Wallace YODER, Patrick Dwaine WARDEN, Chase Cherek SCHOFIELD, Robert Charles BRADLEY, Anthony Christopher MORRIS, Joshua David BARNES, William Cole KOSTER, Ian Kendall BALK, James Chandler LIGGETT
  • Publication number: 20240043556
    Abstract: Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Application
    Filed: March 10, 2023
    Publication date: February 8, 2024
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Robert Kendall MORRISON, Zili AN, Karen Jane Meyrick MORRISON, Josh SNYDER, Xiao-Chi JIA
  • Publication number: 20230346968
    Abstract: Antibody drug conjugates (ADC’s) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC’s of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Application
    Filed: December 14, 2022
    Publication date: November 2, 2023
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Daulet SATPAYEV, Robert Kendall MORRISON, Karen Jane Meyrick MORRISON, Jean GUDAS, Aya JAKOBOVITS, Michael TORGOV, Zili AN
  • Patent number: 11754732
    Abstract: Disclosed herein are earthquake detection devices capable of initiating a safety response in the event of an earthquake. The earthquake detection devices comprise a plurality of three-component accelerometers for measuring acceleration in three directions; and a processing unit for: receiving acceleration measurements from each of the plurality of accelerometers, determining if the acceleration measurements meet or exceed a predetermined threshold value and sending a signal to one or more transducers.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: September 12, 2023
    Assignee: eQuake Systems Inc.
    Inventors: Robert Kendall, Douglas Arnold Goble
  • Patent number: 11634503
    Abstract: Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: April 25, 2023
    Assignees: AGENSYS, INC., SEAGEN INC.
    Inventors: Robert Kendall Morrison, Zili An, Karen Jane Meyrick Morrison, Josh Snyder, Xiao-Chi Jia
  • Publication number: 20230091659
    Abstract: An unmanned aerial vehicle capable of vertical takeoff and landing carries a remote sensing platform to a high altitude cruising altitude and flies over a target area, collecting remote sensing imagery before returning to earth. Instead of being piloted remotely, the vehicle employs an autonomous flight control system.
    Type: Application
    Filed: June 21, 2022
    Publication date: March 23, 2023
    Inventors: Robert Kendall, Roelof Jonkman, Samuel Talaber
  • Patent number: 11559582
    Abstract: Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: January 24, 2023
    Assignees: AGENSYS, INC., SEAGEN INC.
    Inventors: Daulet Satpayev, Robert Kendall Morrison, Karen Jane Meyrick Morrison, Jean Gudas, Aya Jakobovits, Michael Torgov, Zili An
  • Publication number: 20230011867
    Abstract: A system for powering 100% of an oil and gas workover rig's operations with a battery energy storage system (“BESS”). The system consists of three major interconnected components: a BESS, a power conversion system (“PCS”), and a workover rig. The power system is specifically designed for a retrofitted electro-mechanical workover rig (with either an alternating current or direct current electric drive) which is compatible with the BESS. Unlike other emerging industrial applications, a battery cannot be mounted on the workover rig due to logistical and size constraints, thus requiring a novel modular and mobile system design.
    Type: Application
    Filed: July 6, 2022
    Publication date: January 12, 2023
    Applicant: Bazean Corp.
    Inventors: Abhishek Arya, Robert Kendall, Jeffrey Michael LeBlanc, Samuel Newman
  • Publication number: 20220404273
    Abstract: A UAV-carried surveillance and remote sensing platform is launched from a high altitude and flies over a target area, collecting remote sensing imagery before returning to earth. The UAV may be towed to a desired altitude by a powered aircraft or a balloon and then launched for cruising over a target area while capturing data. Instead of being piloted remotely, the UAV employs an autonomous flight control system.
    Type: Application
    Filed: June 21, 2022
    Publication date: December 22, 2022
    Inventors: Robert Kendall, Roelof Jonkman, Samuel Talaber
  • Publication number: 20220404272
    Abstract: A system for airborne remote sensing comprises an array of remote imaging sensors and supporting equipment configured for a combined larger field of view and provided by any of the array of remote imaging sensors alone. The array is mounted in a housing for attachment to a wing or elsewhere on an aircraft. Data collected by the array may be stitched together to provide an image of a larger area than can be acquired by any one of the remote imaging sensors. The data may be stored onboard the aircraft or transmitted to a ground receiver for analysis. The array of remote imaging sensors thus allows for more effective use of an aircraft for activities such as hydrocarbon leak detection and pipeline right-of-way monitoring.
    Type: Application
    Filed: June 21, 2022
    Publication date: December 22, 2022
    Inventors: Robert Kendall, Roelof Jonkman, Samuel Talaber
  • Publication number: 20220404271
    Abstract: A system for airborne remote sensing comprises an array of remote sensing devices configured for being towed by an aircraft. Each of the array of remote sensing devices is configured for lateral separation in flight, to provide a large coverage area than any of the array of remote sensing devices can cover by itself. Onboard electronics comprise sensors, such as a forward imaging infrared camera for capturing data in flight. By analyzing the data collected by the remote sensing system, various types of information can be generated, such as hydrocarbon leak detection.
    Type: Application
    Filed: June 21, 2022
    Publication date: December 22, 2022
    Applicant: Mesos LLC
    Inventors: Robert Kendall, Roelof Jonkman
  • Publication number: 20210356612
    Abstract: Disclosed herein are earthquake detection devices capable of initiating a safety response in the event of an earthquake. The earthquake detection devices comprise a plurality of three-component accelerometers for measuring acceleration in three directions; and a processing unit for: receiving acceleration measurements from each of the plurality of accelerometers, determining if the acceleration measurements meet or exceed a predetermined threshold value and sending a signal to one or more transducers.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 18, 2021
    Inventors: Robert KENDALL, Douglas Arnold GOBLE
  • Publication number: 20210283268
    Abstract: Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Application
    Filed: December 15, 2020
    Publication date: September 16, 2021
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Daulet SATPAYEV, Robert Kendall MORRISON, Karen Jane Meyrick MORRISON, Jean GUDAS, Aya JAKOBOVITS, Michael TORGOV, Zili AN
  • Patent number: 11016647
    Abstract: A method comprises: sending, to a client, data specifying a plurality of commands for use in producing a design; receiving, from the client, one of the plurality of commands, wherein the received command is for creating or modifying a new or existing element of the design, respectively; updating a data structure associated with the design in accordance with the command, wherein the update comprises adding or modifying data associated with the new or existing element, respectively; and sending, to the client, data for enabling the new or modified element to be represented via a user interface.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: May 25, 2021
    Inventors: Andrew James Armstrong, Fergus Cosmo Robert Kendall
  • Publication number: 20210127829
    Abstract: Disclosed are various embodiments for collection container scanning A storage rack is provided that includes a base, a pair of opposed ends connected to and extending upward from the base, and tiers connected to and extending between the ends. Each of the tiers has supports adapted for supporting collection containers A capture manager captures an image of the storage rack, and determines an individual location of one of the collection containers based on generating a decoded representation of an identifier appearing in the image. The storage rack includes a base with a recessed portion for stacking the storage rack on an identical storage rack.
    Type: Application
    Filed: December 20, 2019
    Publication date: May 6, 2021
    Inventors: Will Isaac Thomason, Robert Kendall Ufford, Hilario Alberto Urquieta
  • Publication number: 20210095043
    Abstract: Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Application
    Filed: May 4, 2020
    Publication date: April 1, 2021
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Robert Kendall MORRISON, Zili AN, Karen Jane Meyrick MORRISON, Josh SNYDER, Xiao-Chi JIA
  • Patent number: 10894090
    Abstract: Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: January 19, 2021
    Assignees: AGENSYS, INC., SEAGEN INC.
    Inventors: Daulet Satpayev, Robert Kendall Morrison, Karen Jane Meyrick Morrison, Jean Gudas, Aya Jakobovits, Michael Torgov, Zili An
  • Publication number: 20200325715
    Abstract: A mounting assembly is disclosed. The mounting assembly may include a surface mounting portion and a load mounting portion connected by an intervening gravity hinge portion. The gravity hinge portion may be configured, in accordance with some embodiments, to permit the load mounting portion to be deflected away from a nominal azimuth position and to return to that position under the action of gravity. In this manner, the mounting assembly may be configured to maintain a desired alignment of a given load hosted thereby, as well as absorb impact thereto. In accordance with some embodiments, the gravity hinge portion also may include one or more realignment assistance features configured to assist with returning to the nominal azimuth position.
    Type: Application
    Filed: April 14, 2020
    Publication date: October 15, 2020
    Inventors: Robert William Sengstaken, JR., Robert Kendall Ufford
  • Patent number: RE48389
    Abstract: Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: January 12, 2021
    Assignees: AGENSYS, INC., SEAGEN INC.
    Inventors: Daulet Satpayev, Robert Kendall Morrison, Karen Jane Meyrick Morrison, Jean Gudas, Aya Jakobovits, Michael Torgov, Zili An